TELA Bio, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
TELA Bio, Inc. (TELA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $895.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-25
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $0.00.
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $0.00.
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $2.00K.
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-03-31 was $1.37M.
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $895.00K, a 34.96% decline from fiscal 2022.
- TELA Bio, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.38M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $895.00K 10-K · filed 2026-03-25 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $0.00 derived: sum of 2 quarters · filed 2025-03-21 | $2.00K derived: sum of 3 quarters · filed 2025-03-21 | $1.38M 10-K · filed 2025-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.38M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.38M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $1.37M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |